Letter: Remnant Cholesterol as a Predictor of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction

Abstract

Get full access to this article

View all access options for this article.

References

Yılmaz

Seçkin

Ünlü

Letter: remnant cholesterol and no-reflow in STEMI: considerations on endpoint definition, confounding, and validation. Angiology. 2026. doi:10.1177/00033197261427073

Dogan

Barman

Ebeoglu

, et al. Remnant cholesterol as a predictor of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction. Angiology. Published online December 27, 2025. doi:10.1177/00033197251395822

Ibanez

James

Agewall

, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119-177.

Byrne

Rossello

Coughlan

, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720-3826.

Pitt

Loscalzo

Ycas

Raichlen

JS.

Lipid levels after acute coronary syndromes. J Am Coll Cardiol. 2008;51(15):1440-1445.

Mach

Koskinas

van Lennep

, et al. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2025;46(42):4359-4378.